Global Varicose Vein Treatment Market Projected to Attain $589.06 Mn by 2025 at 5.7% CAGR, Says AMR
PORTLAND, Oregon, March 13, 2019 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Varicose Vein Treatment Market by Procedure (Injection Sclerotherapy, Endovenous Ablation, Surgical Ligation and Stripping), Product (sclerotherapy injection, Ablation devices and others) and End User (Hospitals, Clinics, and Ambulatory centers): Global Opportunity Analysis and Industry Forecast, 2018 - 2025". According to the report, the global varicose vein treatment market accounted for $376.64 million in 2017 and is anticipated to garner $589.06 million by 2025, registering a CAGR of 5.7% during the forecast period, 2018-2025.
https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
The growth of the global varicose vein treatment market is driven by the rise in incidences of varicose vein problem, increase in geriatric population, and technological advancements in varicose vein treatment devices. Additionally, growth of awareness in emerging economies would provide lucrative opportunities to emerging market players in the near future. However, dearth of skilled healthcare professionals and occasional product recall impede market growth.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5184
Injection sclerotherapy segment projected to occupy the largest share in the near future.
By procedure, the injection sclerotherapy segment generated almost three-fifths of the global revenue in 2017 and is expected to continue its dominance through 2025, owing to the accurate nature of its result. However, the endovenous ablation segment is expected to grow at the highest CAGR of 6.9% during the forecast period, owing to its ability to eliminate the collapsed vein through the body's natural process.
Commercial use segment to dominate the global market through 2025
By product, ablation devices segment is poised to encounter the highest growth from 2018 to 2025, a CAGR of 7.3%, as these devices are non-invasive and reduce recovery time. However, the sclerotherapy injection segment is projected to remain the dominant segment through the forecast period and occupy more than half of the global share.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5184
Asia-Pacific to continue dominating the global market
Regionally, Asia-Pacific would grow at the highest CAGR of 7.8% from 2018 to 2025, on account of rising consumer awareness, increase in geriatric population, and the growing adoption of advanced technology such as laser ablation and radiofrequency ablation.
Key market players
The key players analyzed in the report include Medtronic, Lumenis, Alma Lasers Ltd., Angiodynamics, Inc., Biolitec AG, BTG PLC, Energist Ltd., Sciton Inc., WONTECH Co., Ltd., and Syneron. They have adopted different strategies including collaborations, joint ventures, partnerships, expansions, mergers & acquisitions, and others to gain a strong position in the industry.
Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree
Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.
Similar Reports:
Ablation Devices Market - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
View original content:http://www.prnewswire.com/news-releases/global-varicose-vein-treatment-market-projected-to-attain-589-06-mn-by-2025-at-5-7-cagr-says-amr-300811603.html
SOURCE Allied Market Research
